Standard

Synthesis and Analgesic Activity of Cridanimod–Monoterpene Conjugates. / Anikev, Danil D.; Filippova, Anastasia Yu; Yarovaya, Olga I. и др.

в: Scientia Pharmaceutica, Том 94, № 3, 63, 31.07.2026.

Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование

Harvard

Anikev, DD, Filippova, AY, Yarovaya, OI, Tishchenko, SA, Pavlova, AV, Sonina, AA, Kovaleva, KS, Khvostov, MV, Tolstikova, TG, Petrov, AY & Salakhutdinov, NF 2026, 'Synthesis and Analgesic Activity of Cridanimod–Monoterpene Conjugates', Scientia Pharmaceutica, Том. 94, № 3, 63. https://doi.org/10.3390/scipharm94030063

APA

Anikev, D. D., Filippova, A. Y., Yarovaya, O. I., Tishchenko, S. A., Pavlova, A. V., Sonina, A. A., Kovaleva, K. S., Khvostov, M. V., Tolstikova, T. G., Petrov, A. Y., & Salakhutdinov, N. F. (2026). Synthesis and Analgesic Activity of Cridanimod–Monoterpene Conjugates. Scientia Pharmaceutica, 94(3), [63]. https://doi.org/10.3390/scipharm94030063

Vancouver

Anikev DD, Filippova AY, Yarovaya OI, Tishchenko SA, Pavlova AV, Sonina AA и др. Synthesis and Analgesic Activity of Cridanimod–Monoterpene Conjugates. Scientia Pharmaceutica. 2026 июль 31;94(3):63. doi: 10.3390/scipharm94030063

Author

Anikev, Danil D. ; Filippova, Anastasia Yu ; Yarovaya, Olga I. и др. / Synthesis and Analgesic Activity of Cridanimod–Monoterpene Conjugates. в: Scientia Pharmaceutica. 2026 ; Том 94, № 3.

BibTeX

@article{260c2a0e99aa4eca9d404302d2be43f2,
title = "Synthesis and Analgesic Activity of Cridanimod–Monoterpene Conjugates",
abstract = "Cridanimod (acridoneacetic acid), the active ingredient of the immunomodulatory drug Cycloferon{\textregistered}, has a well-characterized antiviral profile, but an unexplored analgesic potential. Bornane monoterpenes, notably (+)-camphor and (−)-fenchone, are established scaffolds for analgesic drug design. We therefore synthesized thirteen cridanimod–monoterpene conjugates—seven amides, three acylhydrazones, and three esters—by EDCI/DMAP-mediated coupling or CDI/DBU-promoted esterification, and evaluated them in mice at an oral dose of 10.0 mg/kg in the acetic acid writhing and hot plate tests, with diclofenac sodium (10.0 mg/kg) as the reference. Acridoneacetic acid and Cycloferon{\textregistered} were themselves inactive in both assays. By contrast, six of the thirteen conjugates were significantly active (p < 0.05) in at least one test, with distinct leads in each: amide 19 matched diclofenac in the writhing test (−63.7% vs. −64.4%), whereas acylhydrazone 23 exceeded diclofenac in the hot plate test (+43.9% vs. +25.7%). The divergent profiles suggest that different structural subclasses engage peripheral and central antinociceptive mechanisms. Conjugation thus converts an analgesically inactive immunomodulator into a substance yielding analgesics that match or exceed a standard NSAID at the same oral dose, providing a promising starting point for the development of new pain-relieving agents.",
keywords = "Cycloferon{\textregistered}, acridoneacetic acid, analgesic activity, camphor, cridanimod, fenchone, hot plate test, monoterpenes, structure–activity relationship, writhing test, криданимод, акридонуксусная кислота, Циклоферон{\textregistered}, монотерпены, камфора, фенхон, анальгетическая активность, тест «корчи», тест «горячая пластина», взаимосвязь «структура–активность»",
author = "Anikev, {Danil D.} and Filippova, {Anastasia Yu} and Yarovaya, {Olga I.} and Tishchenko, {Serafim A.} and Pavlova, {Alla V.} and Sonina, {Alina A.} and Kovaleva, {Kseniya S.} and Khvostov, {Mikhail V.} and Tolstikova, {Tatyana G.} and Petrov, {Andrey Yu.} and Salakhutdinov, {Nariman F.}",
note = "Anikev, D.D.; Filippova, A.Y.; Yarovaya, O.I.; Tishchenko, S.A.; Pavlova, A.V.; Sonina, A.A.; Kovaleva, K.S.; Khvostov, M.V.; Tolstikova, T.G.; Petrov, A.Y.; et al. Synthesis and Analgesic Activity of Cridanimod–Monoterpene Conjugates. Sci. Pharm. 2026, 94, 63. https://doi.org/10.3390/scipharm94030063 This work was financially supported by the Russian Science Foundation and the Government of the Novosibirsk region (Project № 26-23-20046). ",
year = "2026",
month = jul,
day = "31",
doi = "10.3390/scipharm94030063",
language = "English",
volume = "94",
journal = "Scientia Pharmaceutica",
issn = "2218-0532",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "3",

}

RIS

TY - JOUR

T1 - Synthesis and Analgesic Activity of Cridanimod–Monoterpene Conjugates

AU - Anikev, Danil D.

AU - Filippova, Anastasia Yu

AU - Yarovaya, Olga I.

AU - Tishchenko, Serafim A.

AU - Pavlova, Alla V.

AU - Sonina, Alina A.

AU - Kovaleva, Kseniya S.

AU - Khvostov, Mikhail V.

AU - Tolstikova, Tatyana G.

AU - Petrov, Andrey Yu.

AU - Salakhutdinov, Nariman F.

N1 - Anikev, D.D.; Filippova, A.Y.; Yarovaya, O.I.; Tishchenko, S.A.; Pavlova, A.V.; Sonina, A.A.; Kovaleva, K.S.; Khvostov, M.V.; Tolstikova, T.G.; Petrov, A.Y.; et al. Synthesis and Analgesic Activity of Cridanimod–Monoterpene Conjugates. Sci. Pharm. 2026, 94, 63. https://doi.org/10.3390/scipharm94030063 This work was financially supported by the Russian Science Foundation and the Government of the Novosibirsk region (Project № 26-23-20046).

PY - 2026/7/31

Y1 - 2026/7/31

N2 - Cridanimod (acridoneacetic acid), the active ingredient of the immunomodulatory drug Cycloferon®, has a well-characterized antiviral profile, but an unexplored analgesic potential. Bornane monoterpenes, notably (+)-camphor and (−)-fenchone, are established scaffolds for analgesic drug design. We therefore synthesized thirteen cridanimod–monoterpene conjugates—seven amides, three acylhydrazones, and three esters—by EDCI/DMAP-mediated coupling or CDI/DBU-promoted esterification, and evaluated them in mice at an oral dose of 10.0 mg/kg in the acetic acid writhing and hot plate tests, with diclofenac sodium (10.0 mg/kg) as the reference. Acridoneacetic acid and Cycloferon® were themselves inactive in both assays. By contrast, six of the thirteen conjugates were significantly active (p < 0.05) in at least one test, with distinct leads in each: amide 19 matched diclofenac in the writhing test (−63.7% vs. −64.4%), whereas acylhydrazone 23 exceeded diclofenac in the hot plate test (+43.9% vs. +25.7%). The divergent profiles suggest that different structural subclasses engage peripheral and central antinociceptive mechanisms. Conjugation thus converts an analgesically inactive immunomodulator into a substance yielding analgesics that match or exceed a standard NSAID at the same oral dose, providing a promising starting point for the development of new pain-relieving agents.

AB - Cridanimod (acridoneacetic acid), the active ingredient of the immunomodulatory drug Cycloferon®, has a well-characterized antiviral profile, but an unexplored analgesic potential. Bornane monoterpenes, notably (+)-camphor and (−)-fenchone, are established scaffolds for analgesic drug design. We therefore synthesized thirteen cridanimod–monoterpene conjugates—seven amides, three acylhydrazones, and three esters—by EDCI/DMAP-mediated coupling or CDI/DBU-promoted esterification, and evaluated them in mice at an oral dose of 10.0 mg/kg in the acetic acid writhing and hot plate tests, with diclofenac sodium (10.0 mg/kg) as the reference. Acridoneacetic acid and Cycloferon® were themselves inactive in both assays. By contrast, six of the thirteen conjugates were significantly active (p < 0.05) in at least one test, with distinct leads in each: amide 19 matched diclofenac in the writhing test (−63.7% vs. −64.4%), whereas acylhydrazone 23 exceeded diclofenac in the hot plate test (+43.9% vs. +25.7%). The divergent profiles suggest that different structural subclasses engage peripheral and central antinociceptive mechanisms. Conjugation thus converts an analgesically inactive immunomodulator into a substance yielding analgesics that match or exceed a standard NSAID at the same oral dose, providing a promising starting point for the development of new pain-relieving agents.

KW - Cycloferon®

KW - acridoneacetic acid

KW - analgesic activity

KW - camphor

KW - cridanimod

KW - fenchone

KW - hot plate test

KW - monoterpenes

KW - structure–activity relationship

KW - writhing test

KW - криданимод

KW - акридонуксусная кислота

KW - Циклоферон®

KW - монотерпены

KW - камфора

KW - фенхон

KW - анальгетическая активность

KW - тест «корчи»

KW - тест «горячая пластина»

KW - взаимосвязь «структура–активность»

UR - https://www.mendeley.com/catalogue/3d872590-4f78-30a1-ad26-eb75db9f5dda/

UR - https://www.scopus.com/pages/publications/105052575312

U2 - 10.3390/scipharm94030063

DO - 10.3390/scipharm94030063

M3 - Article

VL - 94

JO - Scientia Pharmaceutica

JF - Scientia Pharmaceutica

SN - 2218-0532

IS - 3

M1 - 63

ER -

ID: 85310481